• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用生物信息学分析鉴定非酒精性脂肪性肝病中的关键通路和基因

Identification of key pathways and genes in nonalcoholic fatty liver disease using bioinformatics analysis.

作者信息

Liu Jingqi, Lin Bogeng, Chen Zhiqing, Deng Manxiang, Wang Ye, Wang Jisu, Chen Luling, Zhang Zhenyu, Xiao Xueling, Chen Chunlin, Song Yang

机构信息

Department of Geriatrics, Zhongshan Hospital affiliated to Xiamen University, Xiamen, Fujian, China.

Department of Gastroenterology, Zhongshan Hospital affiliated to Xiamen University, Xiamen, Fujian, China.

出版信息

Arch Med Sci. 2020 Mar 2;16(2):374-385. doi: 10.5114/aoms.2020.93343. eCollection 2020.

DOI:10.5114/aoms.2020.93343
PMID:32190149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7069441/
Abstract

INTRODUCTION

Nonalcoholic fatty liver disease (NAFLD) is one of the most common types of liver disease in the world. However, the molecular mechanisms regulating the development of NAFLD have remained unclear.

MATERIAL AND METHODS

In the present study, we analyzed two public datasets (GSE48452 and GSE89632) to identify differentially expressed mRNAs in the progression of NAFLD. Next, we performed bioinformatics analysis to explore key pathways underlying NAFLD development.

RESULTS

Gene Ontology (GO) analysis showed that differentially expressed genes (DEGs) were mainly involved in regulating a series of metabolism-related pathways (including proteolysis and lipid metabolism), cell proliferation and adhesion, the inflammatory response, and the immune response. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that DEGs in NAFLD were mainly enriched in the insulin signaling pathway, peroxisome proliferator-activated receptor (PPAR) signaling pathway, and p53 signaling pathway. We also constructed protein-protein interaction (PPI) networks for these DEGs. Interestingly, we observed that key hub nodes in PPI networks were also associated with the progression of hepatocellular carcinoma (HCC).

CONCLUSIONS

Taken together, our analysis revealed that a series of pathways, such as metabolism and PPAR signaling pathways, were involved in NAFLD development. Moreover, we observed that many DEGs in NAFLD were also dysregulated in HCC. Although further validation is still needed, we believe this study could provide useful information to explore the potential candidate biomarkers for diagnosis, prognosis, and drug targets of NAFLD.

摘要

引言

非酒精性脂肪性肝病(NAFLD)是世界上最常见的肝病类型之一。然而,调节NAFLD发展的分子机制仍不清楚。

材料与方法

在本研究中,我们分析了两个公共数据集(GSE48452和GSE89632),以鉴定NAFLD进展过程中差异表达的mRNA。接下来,我们进行了生物信息学分析,以探索NAFLD发展的关键途径。

结果

基因本体论(GO)分析表明,差异表达基因(DEGs)主要参与调节一系列与代谢相关的途径(包括蛋白水解和脂质代谢)、细胞增殖和黏附、炎症反应以及免疫反应。京都基因与基因组百科全书(KEGG)途径分析表明,NAFLD中的DEGs主要富集于胰岛素信号通路、过氧化物酶体增殖物激活受体(PPAR)信号通路和p53信号通路。我们还构建了这些DEGs的蛋白质-蛋白质相互作用(PPI)网络。有趣的是,我们观察到PPI网络中的关键枢纽节点也与肝细胞癌(HCC)的进展有关。

结论

综上所述,我们的分析表明,一系列途径,如代谢和PPAR信号通路,参与了NAFLD的发展。此外,我们观察到NAFLD中的许多DEGs在HCC中也失调。尽管仍需要进一步验证,但我们相信这项研究可以为探索NAFLD的诊断、预后和药物靶点的潜在候选生物标志物提供有用的信息。

相似文献

1
Identification of key pathways and genes in nonalcoholic fatty liver disease using bioinformatics analysis.运用生物信息学分析鉴定非酒精性脂肪性肝病中的关键通路和基因
Arch Med Sci. 2020 Mar 2;16(2):374-385. doi: 10.5114/aoms.2020.93343. eCollection 2020.
2
Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.生物信息学分析揭示了与非酒精性脂肪性肝病和非酒精性脂肪性肝炎相关的新核心基因。
Gene. 2020 Jun 5;742:144549. doi: 10.1016/j.gene.2020.144549. Epub 2020 Mar 14.
3
Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease.生物信息学分析探索非酒精性脂肪性肝病中的潜在枢纽基因。
Front Genet. 2021 Oct 29;12:772487. doi: 10.3389/fgene.2021.772487. eCollection 2021.
4
Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure.鉴定非酒精性脂肪性肝病和心力衰竭发病机制关联的共同特征基因和途径。
Front Immunol. 2024 Sep 16;15:1424308. doi: 10.3389/fimmu.2024.1424308. eCollection 2024.
5
NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer.NUSAP1可能是预防非酒精性脂肪性肝病进展为肝癌的潜在靶点。
Front Pharmacol. 2022 Apr 1;13:823140. doi: 10.3389/fphar.2022.823140. eCollection 2022.
6
Identification of genes and key pathways underlying the pathophysiological association between nonalcoholic fatty liver disease and atrial fibrillation.鉴定非酒精性脂肪性肝病与心房颤动之间病理生理关联的相关基因和关键途径。
BMC Med Genomics. 2022 Jul 5;15(1):150. doi: 10.1186/s12920-022-01300-1.
7
The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.通过高通量数据的生物信息学分析鉴定肝细胞癌中的关键基因和信号通路。
Med Oncol. 2017 Jun;34(6):101. doi: 10.1007/s12032-017-0963-9. Epub 2017 Apr 21.
8
The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis.差异表达基因和免疫细胞浸润在非酒精性脂肪性肝炎(NASH)向肝细胞癌(HCC)进展中的作用:基于生物信息学分析的新探索
Nucleosides Nucleotides Nucleic Acids. 2024;43(12):1415-1430. doi: 10.1080/15257770.2024.2310044. Epub 2024 Feb 6.
9
Shared Genes and Molecular Mechanisms between Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma Established by WGCNA Analysis.通过加权基因共表达网络分析(WGCNA)建立的非酒精性脂肪性肝病与肝细胞癌之间的共享基因和分子机制
Glob Med Genet. 2023 Jul 10;10(3):144-158. doi: 10.1055/s-0043-1768957. eCollection 2023 Sep.
10
Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments.通过生物信息学分析和动物实验鉴定膳食晚期糖基化终产物诱导的非酒精性脂肪性肝病的关键基因和关键途径。
Mol Med Rep. 2020 Feb;21(2):685-694. doi: 10.3892/mmr.2019.10872. Epub 2019 Dec 9.

引用本文的文献

1
Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis.基于机器学习整合的分析,通过生物信息学分析确定非酒精性脂肪性肝病中炎症与免疫反应之间的交联。
Heliyon. 2024 Jun 29;10(14):e32783. doi: 10.1016/j.heliyon.2024.e32783. eCollection 2024 Jul 30.
2
Kaempferol Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis (NASH) by Suppressing Neutrophil-Mediated NLRP3-ASC/TMS1-Caspase 3 Signaling.山奈酚通过抑制中性粒细胞介导的 NLRP3-ASC/TMS1-Caspase 3 信号通路缓解非酒精性脂肪性肝炎(NASH)肝损伤。
Molecules. 2024 Jun 3;29(11):2630. doi: 10.3390/molecules29112630.
3

本文引用的文献

1
Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病
Adv Exp Med Biol. 2017;960:443-467. doi: 10.1007/978-3-319-48382-5_19.
2
Insulin Resistance, Obesity and Lipotoxicity.胰岛素抵抗、肥胖与脂毒性
Adv Exp Med Biol. 2017;960:277-304. doi: 10.1007/978-3-319-48382-5_12.
3
Identification of Key Candidate Genes and Pathways in Colorectal Cancer by Integrated Bioinformatical Analysis.综合生物信息学分析鉴定结直肠癌的关键候选基因和途径。
Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension.
进行性和消退性肝纤维化及门静脉高压的转录组特征
iScience. 2024 Feb 20;27(3):109301. doi: 10.1016/j.isci.2024.109301. eCollection 2024 Mar 15.
4
Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review.瘦人非酒精性脂肪性肝病(NAFLD)的遗传和表观遗传决定因素:一项系统综述。
Transl Gastroenterol Hepatol. 2023 Dec 6;9:11. doi: 10.21037/tgh-23-31. eCollection 2024.
5
Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?非酒精性脂肪性肝病、代谢综合征与2型糖尿病:我们如今处于什么状况?
Arch Med Sci. 2022 Jun 3;19(4):884-894. doi: 10.5114/aoms/150639. eCollection 2023.
6
Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis.基于微阵列检测非酒精性脂肪性肝病肝纤维化进展中关键过表达基因:蛋白质-蛋白质相互作用网络分析
Curr Med Chem. 2024;31(23):3631-3652. doi: 10.2174/0929867330666230516123028.
7
Proangiogenic role of circRNA-007371 in liver fibrosis.环状 RNA-007371 在肝纤维化中的促血管生成作用。
Cell Prolif. 2023 Jun;56(6):e13432. doi: 10.1111/cpr.13432. Epub 2023 Feb 28.
8
Mechanism of action of against non-alcoholic fatty liver disease: Insights from systems pharmacology and molecular docking approaches.[药物名称]治疗非酒精性脂肪性肝病的作用机制:来自系统药理学和分子对接方法的见解
Saudi Pharm J. 2022 Nov;30(11):1572-1588. doi: 10.1016/j.jsps.2022.09.001. Epub 2022 Sep 14.
9
Network pharmacology analysis to explore mechanism of Three Flower Tea against nonalcoholic fatty liver disease with experimental support using high-fat diet-induced rats.网络药理学分析以探究三花茶对高脂饮食诱导大鼠非酒精性脂肪性肝病的作用机制并提供实验支持。
Chin Herb Med. 2022 Mar 12;14(2):273-282. doi: 10.1016/j.chmed.2022.03.002. eCollection 2022 Apr.
10
Combined Analysis of Expression Profiles in a Mouse Model and Patients Identified BHMT2 as a New Regulator of Lipid Metabolism in Metabolic-Associated Fatty Liver Disease.在小鼠模型和患者中进行表达谱联合分析,确定BHMT2是代谢相关脂肪性肝病中脂质代谢的新调节因子。
Front Cell Dev Biol. 2021 Nov 11;9:741710. doi: 10.3389/fcell.2021.741710. eCollection 2021.
Int J Mol Sci. 2017 Mar 28;18(4):722. doi: 10.3390/ijms18040722.
4
CircRNA expression pattern and circRNA-miRNA-mRNA network in the pathogenesis of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎发病机制中的环状RNA表达模式及环状RNA-微小RNA-信使RNA网络
Oncotarget. 2016 Oct 11;7(41):66455-66467. doi: 10.18632/oncotarget.12186.
5
Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.利用生物信息学分析鉴定结直肠癌中的关键通路和基因。
Med Oncol. 2016 Oct;33(10):111. doi: 10.1007/s12032-016-0829-6. Epub 2016 Aug 31.
6
Identification of key target genes and pathways in laryngeal carcinoma.喉癌关键靶基因及通路的鉴定
Oncol Lett. 2016 Aug;12(2):1279-1286. doi: 10.3892/ol.2016.4750. Epub 2016 Jun 17.
7
Identification of key genes in glioblastoma-associated stromal cells using bioinformatics analysis.利用生物信息学分析鉴定胶质母细胞瘤相关基质细胞中的关键基因。
Oncol Lett. 2016 Jun;11(6):3999-4007. doi: 10.3892/ol.2016.4526. Epub 2016 May 5.
8
Nonalcoholic fatty liver disease: a systematic review.非酒精性脂肪性肝病:系统评价。
JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370.
9
miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease.微小RNA-103:胰岛素抵抗与非酒精性脂肪性肝病之间的分子联系
World J Gastroenterol. 2015 Jan 14;21(2):511-6. doi: 10.3748/wjg.v21.i2.511.
10
Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.非酒精性脂肪性肝病中肝脏基因表达的改变与肝脏中 n-3 和 n-6 多不饱和脂肪酸水平降低有关。
Hepatology. 2015 May;61(5):1565-78. doi: 10.1002/hep.27695. Epub 2015 Feb 27.